Cytokinetics (CYTK)

$62.25 +0.26 (0.42%)
Market Cap 7.42B
Revenue (ttm) 18.47M
Net Income (ttm) -589.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,191.82%
Debt to Equity Ratio -0.47
Volume 1,542,100
Avg Vol 2,423,676
Day's Range N/A - N/A
Shares Out 119.66M
Stochastic %K 81%
Beta 0.67
Analysts Strong Sell
Price Target $76.26

Company Profile

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It a...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 3000
Address:
350 Oyster Point Boulevard, South San Francisco, United States
1ightningscalps
1ightningscalps Oct. 30 at 8:26 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $65 Call | Enter: $2.33 Exit: $2.91 | Profit: 24.74% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 30 at 4:26 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $61.32 Contracts: $CYTK January 15, 2027 $65 Calls Scale in: $14.92- $18.24 Scale out: $23.21-$29.84 Can Easily Capture: 60% ROI Blended DTE: 443 Days | Join Elites here: https://liquidtheta.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 29 at 7:43 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $65 Call | Enter: $2.00 Exit: $2.56 | Profit: 28.16% ROI | https://1ightning.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 29 at 12:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $60 Call | Enter: $2.58 Exit: $4.42 | Profit: 71.28% ROI | https://1ightning.com
0 · Reply
Dustman16
Dustman16 Oct. 28 at 6:40 PM
$CYTK what was good old Bob saying on CNBC just now? I missed it
2 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 28 at 4:32 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $59.30 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.55- $21.45 Scale out: $27.30-$35.10 Can Easily Capture: 60% ROI Blended DTE: 445 Days | Join Elites here: https://liquidtheta.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 27 at 6:41 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $60 Call | Enter: $2.58 Exit: $4.42 | Profit: 71.28% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 9:25 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $57.83 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.44- $21.31 Scale out: $27.12-$34.88 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 11:56 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $57.83 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.44- $21.31 Scale out: $27.12-$34.88 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 24 at 12:01 PM
$CYTK Current Stock Price: $57.51 Contracts to trade: $60 CYTK Nov 21 2025 Call Entry: $1.89 Exit: $3.69 ROI: 95% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on CYTK
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

Oct 31, 2025, 7:30 AM EDT - 3 hours ago

Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Oct 30, 2025, 11:18 AM EDT - 1 day ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

Oct 28, 2025, 4:32 PM EDT - 2 days ago

Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

Cytokinetics CEO: Advancing a next gen opportunity which could expand addressable market

Oct 28, 2025, 3:08 PM EDT - 2 days ago

Cytokinetics CEO: Advancing a next gen opportunity which could expand addressable market

CYTK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Oct 23, 2025, 1:37 PM EDT - 7 days ago

CYTK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Cytokinetics to Announce Third Quarter Results on November 5, 2025

Oct 22, 2025, 4:00 PM EDT - 8 days ago

Cytokinetics to Announce Third Quarter Results on November 5, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Oct 17, 2025, 4:00 PM EDT - 13 days ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Oct 12, 2025, 8:26 AM EDT - 19 days ago

CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm

Oct 7, 2025, 7:58 AM EDT - 24 days ago

CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Sep 30, 2025, 9:50 AM EDT - 4 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is November 17, 2025

Sep 29, 2025, 4:21 PM EDT - 4 weeks ago

Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is November 17, 2025

Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025

Sep 29, 2025, 7:30 AM EDT - 4 weeks ago

Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025

Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately

Sep 25, 2025, 4:32 PM EDT - 5 weeks ago

Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately

Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program

Sep 24, 2025, 7:30 AM EDT - 5 weeks ago

Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program

Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum

Sep 23, 2025, 4:00 PM EDT - 5 weeks ago

Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Sep 19, 2025, 10:18 AM EDT - 6 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Cytokinetics, Inc. Investigated by the Portnoy Lawfirm

Sep 18, 2025, 4:23 PM EDT - 6 weeks ago

Cytokinetics, Inc. Investigated by the Portnoy Lawfirm

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cytokinetics, Incorporated (CYTK)

Sep 18, 2025, 10:30 AM EDT - 6 weeks ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cytokinetics, Incorporated (CYTK)

Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025

Sep 18, 2025, 7:30 AM EDT - 6 weeks ago

Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025

Cytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes

Sep 16, 2025, 11:45 PM EDT - 6 weeks ago

Cytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes

Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes

Sep 16, 2025, 4:02 PM EDT - 6 weeks ago

Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes

Cytokinetics, Incorporated (CYTK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 2:04 PM EDT - 7 weeks ago

Cytokinetics, Incorporated (CYTK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Sep 3, 2025, 3:32 PM EDT - 2 months ago

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

ARGX BBH BMRN IBB XBI

Cytokinetics, Incorporated (CYTK) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 5:43 PM EDT - 2 months ago

Cytokinetics, Incorporated (CYTK) Presents At Citi's Biopharma Back To School Conference Transcript

Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential

Sep 2, 2025, 2:07 PM EDT - 2 months ago

Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential

Cytokinetics, Incorporated - Exploring The Changing Treatment Paradigm Transcript

Sep 2, 2025, 12:23 PM EDT - 2 months ago

Cytokinetics, Incorporated - Exploring The Changing Treatment Paradigm Transcript

Cytokinetics Stock Jumps. The Biotech's Heart Drug Wows.

Sep 2, 2025, 11:09 AM EDT - 2 months ago

Cytokinetics Stock Jumps. The Biotech's Heart Drug Wows.

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Aug 31, 2025, 12:10 PM EDT - 2 months ago

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Cytokinetics' drug more effective for heart disease symptoms than standard-of-care

Aug 30, 2025, 3:27 AM EDT - 2 months ago

Cytokinetics' drug more effective for heart disease symptoms than standard-of-care

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Aug 30, 2025, 3:18 AM EDT - 2 months ago

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Cytokinetics to Participate in September Investor Conferences

Aug 27, 2025, 4:00 PM EDT - 2 months ago

Cytokinetics to Participate in September Investor Conferences

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025

Aug 25, 2025, 7:30 AM EDT - 2 months ago

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025

Cytokinetics: Specialty Franchise With Aficamten And Ulacamten

Aug 20, 2025, 8:00 AM EDT - 2 months ago

Cytokinetics: Specialty Franchise With Aficamten And Ulacamten

Cytokinetics Names Jim Daly to Board of Directors

Aug 20, 2025, 7:30 AM EDT - 2 months ago

Cytokinetics Names Jim Daly to Board of Directors

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 19, 2025, 4:00 PM EDT - 2 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 4:28 PM EDT - 2 months ago

Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript

Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 7, 2025, 4:00 PM EDT - 3 months ago

Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update

Cytokinetics Merits A Speculative Buy Rating

Jul 25, 2025, 1:23 PM EDT - 3 months ago

Cytokinetics Merits A Speculative Buy Rating

1ightningscalps
1ightningscalps Oct. 30 at 8:26 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $65 Call | Enter: $2.33 Exit: $2.91 | Profit: 24.74% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 30 at 4:26 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $61.32 Contracts: $CYTK January 15, 2027 $65 Calls Scale in: $14.92- $18.24 Scale out: $23.21-$29.84 Can Easily Capture: 60% ROI Blended DTE: 443 Days | Join Elites here: https://liquidtheta.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 29 at 7:43 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $65 Call | Enter: $2.00 Exit: $2.56 | Profit: 28.16% ROI | https://1ightning.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 29 at 12:37 AM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $60 Call | Enter: $2.58 Exit: $4.42 | Profit: 71.28% ROI | https://1ightning.com
0 · Reply
Dustman16
Dustman16 Oct. 28 at 6:40 PM
$CYTK what was good old Bob saying on CNBC just now? I missed it
2 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 28 at 4:32 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $59.30 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.55- $21.45 Scale out: $27.30-$35.10 Can Easily Capture: 60% ROI Blended DTE: 445 Days | Join Elites here: https://liquidtheta.com
0 · Reply
1ightningscalps
1ightningscalps Oct. 27 at 6:41 PM
1ightning® Options Trade Alert (Actionable) | Buy $CYTK Nov 21 $60 Call | Enter: $2.58 Exit: $4.42 | Profit: 71.28% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 9:25 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $57.83 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.44- $21.31 Scale out: $27.12-$34.88 Can Easily Capture: 60% ROI Blended DTE: 446 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 11:56 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $57.83 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.44- $21.31 Scale out: $27.12-$34.88 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 24 at 12:01 PM
$CYTK Current Stock Price: $57.51 Contracts to trade: $60 CYTK Nov 21 2025 Call Entry: $1.89 Exit: $3.69 ROI: 95% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 24 at 9:16 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $57.44 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.44- $21.31 Scale out: $27.12-$34.88 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
CrispDry
CrispDry Oct. 23 at 6:02 PM
$CYTK interesting
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 23 at 12:14 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $54.76 Contracts: $CYTK January 15, 2027 $55 Calls Scale in: $16.49- $20.16 Scale out: $25.66-$32.99 Can Easily Capture: 60% ROI Blended DTE: 450 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
CrispDry
CrispDry Oct. 23 at 1:09 AM
$CYTK anyone have a good comparison of Afi and camzyos?
1 · Reply
buddyopalosam
buddyopalosam Oct. 21 at 9:25 PM
$CYTK buy in the low 50's in November?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 20 at 7:33 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $58.44 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $17.55- $21.45 Scale out: $27.30-$35.10 Can Easily Capture: 60% ROI Blended DTE: 453 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 17 at 10:28 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $58.96 Contracts: $CYTK January 15, 2027 $60 Calls Scale in: $19.39- $23.71 Scale out: $30.17-$38.79 Can Easily Capture: 60% ROI Blended DTE: 455 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
timfris
timfris Oct. 17 at 3:45 PM
$CYTK definitely buy on the dips, will eventually be sold for $100 plus.
0 · Reply
timfris
timfris Oct. 16 at 8:43 PM
$CYTK damn, might have to add more down here. In the long run, this is going to $100.
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 16 at 4:05 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CYTK Current Share Price: $62.80 Contracts: $CYTK January 15, 2027 $65 Calls Scale in: $15.59- $19.06 Scale out: $24.25-$31.18 Can Easily Capture: 60% ROI Blended DTE: 456 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
RonIsWrong
RonIsWrong Oct. 15 at 3:02 PM
$CYTK
1 · Reply
OptionRunners
OptionRunners Oct. 14 at 7:54 PM
$CYTK Buyer of the January 16th 2026 $65 calls 1,800 times for $7.50. Repeat flow.
0 · Reply